At the same time, another group reported that treatment of mice using a selective pharmacological RANKL inhibitor, RANK-Fc, almost completely blocked the occurrence of DMBA/MPA-induced mammary tumours in wild-type mice [32]. Here, TNFRSF11A is linked to breast cancer.